Eva Corey相关文献与解析，生知库 | 链接生命科学的每一步

Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancer

核因子 I 介导的染色质可及性增加驱动前列腺癌向雄激素受体剪接变体依赖性转变

doi:10.1016/j.celrep.2024.115089

Larysa Poluben ,Mannan Nouri ,Jiaqian Liang ,Shaoyong Chen ,Andreas Varkaris ,Betul Ersoy-Fazlioglu ,Olga Voznesensky ,Irene I Lee ,Xintao Qiu ,Laura Cato ,Ji-Heui Seo ,Matthew L Freedman ,Adam G Sowalsky ,Nathan A Lack ,Eva Corey ,Peter S Nelson ,Myles Brown ,Henry W Long ,Joshua W Russo ,Steven P Balk

Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer

利用 HSP70 介导的蛋白质周转对 N-Myc 进行蛋白质稳态扰动可改善神经内分泌前列腺癌的治疗

期刊:Nature Communications

影响因子:14.7

doi:10.1038/s41467-024-50459-x

Pengfei Xu #, Joy C Yang #, Bo Chen #, Shu Ning, Xiong Zhang, Leyi Wang, Christopher Nip, Yuqiu Shen, Oleta T Johnson, Gabriela Grigorean, Brett Phinney, Liangren Liu, Qiang Wei, Eva Corey, Clifford G Tepper, Hong-Wu Chen, Christopher P Evans, Marc A Dall'Era, Allen C Gao, Jason E Gestwicki, Chengfe

Castrate-resistant prostate cancer response to taxane is determined by an HNF1-dependent apoptosis resistance circuit

去势抵抗性前列腺癌对紫杉烷类药物的反应取决于HNF1依赖性细胞凋亡抵抗回路。

期刊:Cell Reports Medicine

影响因子:11.7

doi:10.1016/j.xcrm.2024.101868

Ilya S Senatorov,Joel Bowman,Keith H Jansson,Aian Neil Alilin,Brian J Capaldo,Ross Lake,Morgan Riba,Yasmine C Abbey,Crystal Mcknight,Xiaohu Zhang,Sonam Raj,Michael L Beshiri,Paul Shinn,Holly Nguyen,Craig J Thomas,Eva Corey,Kathleen Kelly

Stromal-derived MAOB promotes prostate cancer growth and progression

基质衍生的 MAOB 促进前列腺癌的生长和进展

期刊:Science Advances

影响因子:11.7

doi:10.1126/sciadv.adi4935

Tianjie Pu, Jing Wang, Jing Wei, Alan Zeng, Jinglong Zhang, Jingrui Chen, Lijuan Yin, Jingjing Li, Tzu-Ping Lin, Jonathan Melamed, Eva Corey, Allen C Gao, Boyang Jason Wu

Cholinergic signaling via muscarinic M1 receptor confers resistance to docetaxel in prostate cancer

通过毒蕈碱 M1 受体的胆碱能信号传导导致前列腺癌对多西他赛产生耐药性

期刊:Cell Reports Medicine

影响因子:11.7

doi:10.1016/j.xcrm.2023.101388

Jing Wang, Jing Wei, Tianjie Pu, Alan Zeng, Varsha Karthikeyan, Baron Bechtold, Karen Vo, Jingrui Chen, Tzu-Ping Lin, Amy P Chang, Eva Corey, Martin Puhr, Helmut Klocker, Zoran Culig, Tyler Bland, Boyang Jason Wu

Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysis

通过单细胞RNA测序分析揭示新型双阴性前列腺癌亚型

期刊:npj Precision Oncology

影响因子:6.8

doi:10.1038/s41698-024-00667-x

Siyuan Cheng ，Lin Li ，Yunshin Yeh ，Yingli Shi ，Omar Franco ，Eva Corey ，Xiuping Yu

Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis

在前列腺癌模型中，雄激素受体和 PI3K/AKT/mTOR 通路的双重靶向可提高抗肿瘤功效并促进细胞凋亡

期刊:Molecular Oncology

影响因子:5

doi:10.1002/1878-0261.13577

Tatsuo Sugawara, Ekaterina Nevedomskaya, Simon Heller, Annika Böhme, Ralf Lesche, Oliver von Ahsen, Sylvia Grünewald, Holly M Nguyen, Eva Corey, Simon J Baumgart, Victoria Georgi, Vera Pütter, Amaury Fernández-Montalván, James D Vasta, Matthew B Robers, Oliver Politz, Dominik Mumberg, Bernard Haendl

Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies

前列腺癌中急性和慢性 CDK12 缺失的分子后果决定了不同的治疗策略

期刊:

影响因子:

doi:10.1101/2024.07.16.603734

Sander Frank, Thomas Persse, Ilsa Coleman, Armand Bankhead 3rd, Dapei Li, Navonil De-Sarkar, Divin Wilson, Dmytro Rudoy, Manasvita Vashisth, Patty Galipeau, Michael Yang, Brian Hanratty, Ruth Dumpit, Colm Morrissey, Eva Corey, R Bruce Montgomery, Michael C Haffner, Colin Pritchard, Valera Vasioukhin

Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation

时间演化揭示了侵袭性神经内分泌小细胞前列腺癌转分化过程中的谱系分化

期刊:Cancer Cell

影响因子:48.8

doi:10.1016/j.ccell.2023.10.009

Chia-Chun Chen ,Wendy Tran ,Kai Song ,Tyler Sugimoto ,Matthew B Obusan ,Liang Wang ,Katherine M Sheu ,Donghui Cheng ,Lisa Ta ,Grigor Varuzhanyan ,Arthur Huang ,Runzhe Xu ,Yuanhong Zeng ,Amirreza Borujerdpur ,Nicholas A Bayley ,Miyako Noguchi ,Zhiyuan Mao ,Colm Morrissey ,Eva Corey ,Peter S Nelson ,Yue Zhao ,Jiaoti Huang ,Jung Wook Park ,Owen N Witte ,Thomas G Graeber

PlexinD1 is a driver and a therapeutic target in advanced prostate cancer

PlexinD1 是晚期前列腺癌的驱动因素和治疗靶点

Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancer

核因子 I 介导的染色质可及性增加驱动前列腺癌向雄激素受体剪接变体依赖性转变

Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer

利用 HSP70 介导的蛋白质周转对 N-Myc 进行蛋白质稳态扰动可改善神经内分泌前列腺癌的治疗

Castrate-resistant prostate cancer response to taxane is determined by an HNF1-dependent apoptosis resistance circuit

去势抵抗性前列腺癌对紫杉烷类药物的反应取决于HNF1依赖性细胞凋亡抵抗回路。

Stromal-derived MAOB promotes prostate cancer growth and progression

基质衍生的 MAOB 促进前列腺癌的生长和进展

Cholinergic signaling via muscarinic M1 receptor confers resistance to docetaxel in prostate cancer

通过毒蕈碱 M1 受体的胆碱能信号传导导致前列腺癌对多西他赛产生耐药性

Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysis

通过单细胞RNA测序分析揭示新型双阴性前列腺癌亚型

Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis

在前列腺癌模型中，雄激素受体和 PI3K/AKT/mTOR 通路的双重靶向可提高抗肿瘤功效并促进细胞凋亡

Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies

前列腺癌中急性和慢性 CDK12 缺失的分子后果决定了不同的治疗策略

Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation

时间演化揭示了侵袭性神经内分泌小细胞前列腺癌转分化过程中的谱系分化